Ethical alarm as Guinea-Bissau hepatitis B trial may become blueprint for US vaccine studies

Experts warn a suspended hepatitis B vaccine trial in Guinea-Bissau could become a blueprint for US studies under RFK Jr., citing concerns about informed consent, conflicts of interest, and weak ethical oversight; the study is paused and under review, with WHO and Africa CDC urging stronger safeguards and a shift toward universal birth-dose vaccination.